Dhiraj Dhoot

Efficacy and safety of terbinafine 500 mg once daily in patients with dermatophytosis

P Ravindra Babu, A. J. S. Pravin, Gaurav Deshmukh et al. · Indian Journal of Dermatology · 2017 · 43 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +15

Acne in Indian population: An epidemiological study evaluating multiple factors

Leelavathy Budamakuntla, Shrichand G. Parasramani, Dhiraj Dhoot et al. · IP Indian Journal of Clinical and Experimental Dermatology · 2020 · 22 citations · Full text

Medicine, Dermatology, Cosmetic Dermatology +14

A Comparative, Three-Arm, Randomized Clinical Trial to Evaluate the Effectiveness and Tolerability of Bilastine vs Fexofenadine vs Levocetirizine at the Standard Dose and Bilastine vs Fexofenadine at Higher Than the Standard Dose (Up-Dosing) vs Levocetirizine and Hydroxyzine (in Combination) in Patients with Chronic Spontaneous Urticaria

Bela Shah, Dhiraj Dhoot, Ankita Choudhary et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 2022 · 17 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

An Open-Label, Randomized, Double-Arm Clinical Trial to Compare the Effectiveness and Safety of Super Bioavailable Itraconazole Capsules and Itraconazole Capsules in the Management of Dermatophytosis in India

Manjunath Shenoy, Dhiraj Dhoot, Harshal Mahajan et al. · Clinical Cosmetic and Investigational Dermatology · 2021 · 16 citations · Full text

Medicine, Dermatology, Pharmacology +14

Effect of bilastine on chronic spontaneous urticaria refractory to levocetrizine: Real world experience in India

Bela Shah, Abhishek De, Aarti Sarda et al. · Dermatologic Therapy · 2020 · 14 citations

Life Sciences, Pharmacology, Pharmacotherapy +7